Clinical trial No longer in our active list Interventional Ages 18 and up

Reducing unnecessary antibiotic use for pneumonia patients

Official title: Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia

Run by The Cleveland Clinic · NCT05568654 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing different ways to reduce unnecessary antibiotic use in pneumonia patients by using quick tests and help from pharmacists to see if it can lead to better treatment outcomes.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment12500 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations12 sites (Vero Beach, Florida and 11 other locations)
Trial IDNCT05568654 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are admitted to a participating hospital with a diagnosis of pneumonia.

Probably not a fit

Patients who may not benefit include those admitted to intensive care within 24 hours, those receiving comfort care only, or those with known pathogens prior to admission.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to minimize the use of broad-spectrum antibiotics in patients with community-acquired pneumonia (CAP) by implementing rapid diagnostic testing and pharmacist-led de-escalation strategies. It will be conducted as a pragmatic, multicenter, cluster randomized controlled trial over three years, comparing four different approaches: rapid diagnostic testing, pharmacist-led de-escalation, a combination of both, and usual care. The goal is to enhance the accuracy of pathogen detection and improve antibiotic stewardship practices following negative culture results.

Why it matters

Potential benefit: If successful, this approach could significantly reduce unnecessary antibiotic exposure and improve patient outcomes in pneumonia treatment.

How similar studies have gone: Other studies have shown promise in reducing antibiotic overuse through targeted therapies, indicating that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for patient's records:

1. Men or women greater than or equal to 18 years of age
2. Admitted to a participating (i.e. enrolled and randomized) hospital
3. Admitting diagnosis of pneumonia

Exclusion Criteria:

1. Admission to intensive care unit within 24 hours of hospital admission
2. Comfort care measures only
3. Cystic fibrosis
4. Discharged from an acute care hospital in the past week
5. Patients not eligible for empiric therapy due to a known pathogen (any positive blood or respiratory cultures in the 72 hours prior to admission)

Where it's running

  • Indian River Hospital
    Vero Beach, Florida, United States
    Recruiting
  • Weston Hospital/Cleveland Clinic Florida
    Weston, Florida, United States
    Recruiting
  • Akron General Hospital
    Akron, Ohio, United States
    Recruiting
  • Avon Hospital
    Avon, Ohio, United States
    Recruiting
  • Lutheran Hospital
    Cleveland, Ohio, United States
    Recruiting
  • Cleveland Clinic Main Campus
    Cleveland, Ohio, United States
    Recruiting
Show 6 more locations
  • Euclid Hospital
    Euclid, Ohio, United States
    Recruiting
  • Fairview Hospital
    Fairview Park, Ohio, United States
    Recruiting
  • Marymount Hospital
    Garfield Heights, Ohio, United States
    Recruiting
  • Hillcrest Hospital
    Mayfield Heights, Ohio, United States
    Recruiting
  • Medina Hospital
    Medina, Ohio, United States
    Recruiting
  • South Pointe Hospital
    Warrensville Heights, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: Michael Rothberg, M.D. — The Cleveland Clinic
  • Study coordinator: Michael Rothberg, M.D.
  • Email: ROTHBEM@ccf.org
  • Phone: 216-445-0719

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.